Your browser doesn't support javascript.
loading
Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells.
Doig, Craig L; Battaglia, Sebastiano; Khanim, Farhat L; Bunce, Christopher M; Campbell, Moray J.
Affiliation
  • Doig CL; Centre for Endocrinology Diabetes & Metabolism, School of Clinical & Experimental Medicine, University of Birmingham, Edgbaston B15 2TT, UK. Electronic address: c.l.doig@bham.ac.uk.
  • Battaglia S; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
  • Khanim FL; School of Biosciences, University of Birmingham, Edgbaston, B15 2TT, UK.
  • Bunce CM; School of Biosciences, University of Birmingham, Edgbaston, B15 2TT, UK.
  • Campbell MJ; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
J Steroid Biochem Mol Biol ; 155(Pt A): 47-55, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26429394
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Hydroxyprostaglandin Dehydrogenases / Epigenesis, Genetic / 3-Hydroxysteroid Dehydrogenases Limits: Humans / Male Language: En Journal: J Steroid Biochem Mol Biol Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2016 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Hydroxyprostaglandin Dehydrogenases / Epigenesis, Genetic / 3-Hydroxysteroid Dehydrogenases Limits: Humans / Male Language: En Journal: J Steroid Biochem Mol Biol Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2016 Document type: Article Country of publication: United kingdom